Financial Statements · Financial Reporting
Asper Biogene OÜ
Official identifier 14265334Record date 31 Dec 2019
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2019
- Period start
- 1 Jan 2019
- Submitted date
- 2 Jul 2020
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 323,817 |
| Balance sheet | Cash and cash equivalents | 83,231 |
| Balance sheet | Current assets | 154,865 |
| Balance sheet | Current liabilities | 133,344 |
| Balance sheet | Equity | 100,273 |
| Balance sheet | Share capital at nominal value | 2,500 |
| Balance sheet | Non-current assets | 168,952 |
| Balance sheet | Non-current liabilities | 90,200 |
| Balance sheet | Retained earnings (loss) from previous periods | 83,723 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -13,956 |
| Income statement scheme 1 | Labour costs | -334,403 |
| Income statement scheme 1 | Revenue | 681,879 |
| Income statement scheme 1 | Annual period profit / loss | 14,050 |
| Income statement scheme 1 | Operating profit (loss) | 12,805 |
| Income statement scheme 1 | Profit (loss) before income tax | 14,050 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 83,723 |
| Note: Labour costs | Employees | 14 |
| Note: Labour costs | Labour costs | 334,403 |
Linked company
Company: Asper Biogene OÜ